- Home
- WOOF vs MPLT Comparison
WOOF vs MPLT Comparison
Compare WOOF & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WOOF | MPLT |
|---|---|---|
| Founded | 1965 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 871.9M | 811.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | WOOF | MPLT |
|---|---|---|
| Price | $3.63 | $19.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $3.90 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 2.8M | 126.2K |
| Earning Date | 06-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.26 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $6,116,462,000.00 | N/A |
| Revenue This Year | $2.61 | N/A |
| Revenue Next Year | $1.63 | N/A |
| P/E Ratio | $81.51 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $12.24 |
| 52 Week High | $4.19 | $21.55 |
Technical Indicators
Market Signals| Indicator | WOOF | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 78.30 | 59.78 |
| Support Level | $3.32 | $16.17 |
| Resistance Level | $3.70 | $20.20 |
| Average True Range (ATR) | 0.18 | 1.18 |
| MACD | 0.11 | 0.15 |
| Stochastic Oscillator | 88.31 | 70.90 |
Price Performance
Historical ComparisonAbout WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.